A robust meta-classification strategy for cancer detection from MS data

被引:37
作者
Bhanot, G
Alexe, G [1 ]
Venkataraghavan, B
Levine, AJ
机构
[1] Thomas J Watson IBM Res, Computat Biol Ctr, Yorktown Hts, NY 10598 USA
[2] Canc Inst New Jersey, Robert Wood Johnson Med Sch & Dent, New Brunswick, NJ USA
[3] Inst Adv Study, Ctr Syst Biol, Princeton, NJ 08540 USA
关键词
biomarker; diagnosis; meta-classifier; pattern extraction; prostate cancer;
D O I
10.1002/pmic.200500192
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We propose a novel method for phenotype identification involving a stringent noise analysis and filtering procedure followed by combining the results of several machine learning tools to produce a robust predictor. We illustrate our method on SELDI-TOF MS prostate cancer data (http:// home.ccr.cancer.gov/ncifdaproteomics/ppatterns.asp). Our method identified 11 proteomic biomarkers and gave significantly improved predictions over previous analyses with these data. We were able to distinguish cancer from non-cancer cases with a sensitivity of 90.31% and a specificity of 98.81%. The proposed method can be generalized to multi-phenotype prediction and other types of data (e.g., microarray data).
引用
收藏
页码:592 / 604
页数:13
相关论文
共 61 条
[31]   Enhancement of sensitivity and resolution of surface-enhanced, laser desorption/lonization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques [J].
Malyarenko, DI ;
Cooke, WE ;
Adam, BL ;
Malik, G ;
Chen, HJ ;
Tracy, ER ;
Trosset, MW ;
Sasinowski, M ;
Semmes, OJ ;
Manos, DM .
CLINICAL CHEMISTRY, 2005, 51 (01) :65-74
[32]   Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data [J].
McShane, LM ;
Radmacher, MD ;
Freidlin, B ;
Yu, R ;
Li, MC ;
Simon, R .
BIOINFORMATICS, 2002, 18 (11) :1462-1469
[33]  
MERZ C, 1998, THESIS UCI
[34]   Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml [J].
Ornstein, DK ;
Rayford, W ;
Fusaro, VA ;
Conrads, TP ;
Ross, SJ ;
Hitt, BA ;
Wiggins, WW ;
Veenstra, TD ;
Liotta, LA ;
Petricoin, EF .
JOURNAL OF UROLOGY, 2004, 172 (04) :1302-1305
[35]   Clinical proteomics: applications for prostate cancer biomarker discovery and detection [J].
Petricoin, EF ;
Ornstein, DK ;
Liotta, LA .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) :322-328
[36]  
Petricoin EF, 2002, J NATL CANCER I, V94, P1576
[37]   Proteomics mind ovarian cancer: Implications for diagnosis and treatment: a critical review of the recent literature [J].
Posadas, EM ;
Davidson, B ;
Kohn, EC .
CURRENT OPINION IN ONCOLOGY, 2004, 16 (05) :478-484
[38]  
PRODROMIDIS AL, 1999, P 16 INT C MACH LEAR, P18
[39]  
Qu YS, 2002, CLIN CHEM, V48, P1835
[40]  
Rumelhart D. E., 1986, PARALLEL DISTRIBUTED, V1